$39.40
+0.86 (+2.23%)
Open$38.71
Previous Close$38.54
Day High$39.44
Day Low$38.71
52W High$51.10
52W Low$14.35
Volume—
Avg Volume310.7K
Market Cap1.84B
P/E Ratio—
EPS$-0.54
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+14.1% upside
Current
$39.40
$39.40
Target
$44.96
$44.96
$33.78
$44.96 avg
$58.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 49.25M | 203.59M | 209.55M |
| Net Income | -52,388,121 | 62.98M | 65.23M |
| Profit Margin | -106.4% | 30.9% | 31.1% |
| EBITDA | -71,481,040 | 113.38M | 119.42M |
| Free Cash Flow | — | 53.53M | 45.52M |
| Rev Growth | — | +1.5% | +13.6% |
| Debt/Equity | — | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |